Amanote Research
Register
Sign In
A Randomised Phase II Study of Interleukin-1 Receptor Antagonist in Acute Stroke Patients
Journal of Neurology, Neurosurgery and Psychiatry
- United Kingdom
doi 10.1136/jnnp.2004.054882
Full Text
Open PDF
Abstract
Available in
full text
Categories
Psychiatry
Mental Health
Neurology
Surgery
Date
October 1, 2005
Authors
H C A Emsley
Publisher
BMJ
Related search
Interleukin-1, Interleukin-1 Receptor, and Interleukin-1 Receptor Antagonist
Proceedings of the Nutrition Society
Medicine
Nutrition
Dietetics
Interleukin-1 Receptor Antagonist in Animal Models of Stroke: A Fair Summing Up?
Journal of Stroke and Cerebrovascular Diseases
Surgery
Neurology
Cardiovascular Medicine
Rehabilitation
Cardiology
Increased Fibrinogen Synthesis in Mice During the Acute Phase Response: Co-Operative Interaction of Interleukin 1, Interleukin 6, and Interleukin 1 Receptor Antagonist
Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia
Investigational New Drugs
Oncology
Pharmacology
Deficiency of Interleukin-1 Receptor Antagonist Responsive to Anakinra
Pediatric Dermatology
Dermatology
Child Health
Pediatrics
Perinatology
Anti-Inflammatory Properties of a Novel Peptide Interleukin 1 Receptor Antagonist
Journal of Neuroinflammation
Molecular Neuroscience
Neurology
Immunology
Cellular
Neuroscience
Multiple Sclerosis: Longitudinal Measurement of Interleukin-1 Receptor Antagonist.
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Interleukin-1 and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Gastric Cancer: A Meta-Analysis
Cancer Epidemiology Biomarkers and Prevention
Medicine
Epidemiology
Oncology
Structure Studies of Recombinant Interleukin-1 Receptor Antagonist Protein
Acta Crystallographica Section A Foundations of Crystallography
